Skip to main content

Funding for Research Areas

The National Cancer Institute reports how appropriated funds are spent based on different categories or classifications, including specific cancer sites, cancer types, diseases related to cancer, as well as types of NCI research mechanisms. The table below identifies funding levels for frequently requested areas of cancer research.

The research areas in this table do not represent the entire NCI research portfolio. Moreover, funding for research areas often overlap, and therefore the total for all research areas does not add to the total NCI budget. For example, funding for a clinical trial on breast cancer would be included in both the Breast Cancer and the Clinical Trials lines in the table below. Similarly, a basic cancer research project may be relevant to cervical, uterine, and ovarian cancers, and relevant amounts would be included in the amounts for all three areas of cancer research.

Download the Data

Funding by Research Areas
(Dollars in Millions)
Disease Area 2013 Actual 2014 Actual 2015 Actual 2016 Actual 2017 Actual 2018 Actual
Total NCI Budget $4,789.0 $4,932.4 $4,952.6 $5,206.2 $5,636.4 $5,927.7
AIDS 261.6 269.2 269.7 266.4 249.0 241.2
Brain & CNS 176.8 180.4 204.8 196.3 219.8 220.9
Breast Cancer 559.2 528.5 543.6 519.9 544.9 574.9
Cervical Cancer 63.5 71.1 57.1 65.6 68.8 71.5
Clinical Trials 676.5 749.8 748.0 801.0 806.6 895.7
Colorectal Cancer 239.0 223.0 209.3 212.2 208.4 256.0
Head & Neck Cancers 40.6 57.1 60.2 58.9 46.4 62.4
Hodgkin Disease 14.7 15.4 13.6 12.8 13.0 13.3
Leukemia 235.3 236.7 246.9 241.0 250.5 258.3
Liver Cancer 64.5 60.0 70.3 75.7 72.7 95.9
Lung Cancer 287.6 254.1 255.8 283.8 320.6 350.1
Melanoma 122.7 126.2 132.8 142.9 153.2 158.4
Multiple Myeloma 45.5 46.6 48.9 52.1 60.7 61.5
Non-Hodgkin Lymphoma 113.9 118.0 122.4 116.7 119.5 121.0
Ovarian Cancer 101.0 91.5 92.8 95.6 110.1 120.8
Pancreatic Cancer 102.0 122.4 125.3 152.6 178.3 182.1
Prostate Cancer 256.3 217.8 228.9 241.0 233.0 239.3
Stomach Cancer 11.2 11.3 13.5 13.3 13.4 14.2
Uterine Cancer 17.9 15.5 13.0 16.8 17.5 17.5

The figures in this table were created using NCI's coding methodology. More information about this methodology, as well as the research projects associated with these and other disease area categories, are available on the NCI Funded Research Portfolio website.

The FY 2018 funds available to the NCI totaled $5.94 billion (includes $300 million in CURES Act funding), reflecting a increase of 5 percent, or $284 million from the previous fiscal year. Under the NCI RPG funding policy for FY 2018, non-competing grants were awarded at 100 percent of the committed level. For more information on NCI's grant funding policy, visit the NCI Division of Extramural Activities website.

  • Posted: